NCT01684124View on ClinicalTrials.gov

An Assessment of the Feasibility and Safety of Conservative Oxygen Therapy in Critically Ill Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Critical Illness
Interventions
OTHER

conservative O2 therapy

target lower O2 saturation

OTHER

standard care

Trial Locations (1)

3079

Austin Hospital, Melbourne

Sponsors

Lead Sponsor

Austin Health
All Listed Sponsors
lead

Austin Health

OTHER_GOV

NCT01684124 - An Assessment of the Feasibility and Safety of Conservative Oxygen Therapy in Critically Ill Patients | Biotech Hunter | Biotech Hunter